Mirati Therapeutics Inc (NASDAQ:MRTX)

36.10
Delayed Data
As of May 18
 +0.40 / +1.12%
Today’s Change
2.70
Today|||52-Week Range
37.62
+97.81%
Year-to-Date
No recent news for Mirati Therapeutics Inc.

Today’s Trading

Previous close35.70
Today’s open35.60
Day’s range35.25 - 36.15
Volume174,889
Average volume (3 months)418,900
Market cap$1.1B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+33.81%
Earnings growth (this year)+1.81%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.39

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd+0.10+1.55%
REPHRecro Pharma Inc+0.69+6.26%
VCELVericel Corp-0.10-0.69%
TRVNTrevena Inc-0.01-0.55%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 10, 2018
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$0.00
Annual profit (last year)-$70.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles M. Baum
CFO, Principal Accounting Officer &
Senior VP
Jamie A. Donadio
Corporate headquarters
San Diego, California

Forecasts